no abstract
Candoni, A., Lazzarotto, D., Papayannidis, C., Piccini, M., Nadali, G., Dargenio, M., Riva, M., Fracchiolla, N., Mellillo, L., Dragonetti, G., Del Principe, M. I., Cattaneo, C., Stulle, M., Pasciolla, C., De Marchi, R., Delia, M., Tisi, M. C., Bonuomo, V., Sciume, M., Spadea, A., Sartor, C., Griguolo, D., Buzzatti, E., Basilico, C. M., Sarlo, C., Piccioni, A. L., Cerqui, E., Lessi, F., Olivieri, A., Fanin, R., Luppi, M., Pagano, L., Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax, <<AMERICAN JOURNAL OF HEMATOLOGY>>, 2023; 98 (4): 80-83. [doi:10.1002/ajh.26846] [https://hdl.handle.net/10807/235316]
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first-line therapy with hypomethylating agents alone or in combination with Venetoclax
Dragonetti, GiuliaMembro del Collaboration Group
;Pagano, LivioWriting – Review & Editing
2023
Abstract
no abstract
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
